HIRSCHMAN ORIN 13D/13G Filings for Evoke Pharma, Inc. (EVOK)

HIRSCHMAN ORIN 13D and 13G filings for Evoke Pharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2021-05-06
4:20 pm
Purchase		 2021-04-30 13G Evoke Pharma, Inc.
EVOK		 HIRSCHMAN ORIN 11,814
5.300%		 1,862increase
(+18.71%)		 Filing
2021-03-25
6:28 pm
Sale		 2021-03-19 13G Evoke Pharma, Inc.
EVOK		 HIRSCHMAN ORIN 9,952
4.400%		 -1,853decrease
(-15.70%)		 Filing
2021-01-20
07:20 am
Purchase		 2021-01-14 13G Evoke Pharma, Inc.
EVOK		 HIRSCHMAN ORIN 11,806
5.300%		 11,806increase
(New Position)		 Filing